UMIN-ICDS Clinical Trial
| Unique ID issued by UMIN | UMIN000060972 |
|---|---|
| Receipt number | R000069772 |
| Scientific Title | The Obuse Study: Second Phase Survey of Musculoskeletal Examinations in a Community-Dwelling Population |
| Date of disclosure of the study information | 2026/03/20 |
| Last modified on | 2026/03/18 11:56:50 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
The Obuse Study: Second Phase Survey of Musculoskeletal Examinations in a Community-Dwelling Population
Acronym
Phase II of the Obuse Study
Scientific Title
The Obuse Study: Second Phase Survey of Musculoskeletal Examinations in a Community-Dwelling Population
Scientific Title:Acronym
Phase II of the Obuse Study
Region
| Japan |
Condition
Condition
Locomotive syndrome, frailty
Classification by specialty
| Orthopedics | Rehabilitation medicine | Adult |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
The purpose of this study is to assess the musculoskeletal health of residents and identify longitudinal changes since the first Obuse Study. By analyzing these shifts over several years, we aim to characterize individuals predisposed to requiring long-term care. These findings will serve as a foundation for implementing effective preventive measures against disability and the need for long-term care within the community.
Basic objectives2
Others
Basic objectives -Others
Preventive care for the elderly
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Questionnaire survey, physical function test, general blood test, plain X-ray, bone mineral density
Key secondary outcomes
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 50 | years-old | <= |
Age-upper limit
| 120 | years-old | >= |
Gender
Male and Female
Key inclusion criteria
General residents of Obuse Town aged 50-89
Participants in the first phase of the Obuse Study
General residents aged 50-89 who did not participate in the first phase of the Obuse Study
Key exclusion criteria
Cases where conducting the survey is difficult, such as severe dementia or difficulty standing and walking.
Others whom the principal investigator deems unsuitable as subjects.
Target sample size
560
Research contact person
Name of lead principal investigator
| 1st name | Jun |
| Middle name | |
| Last name | Takahashi |
Organization
Shinshu University School of Medicine
Division name
Department of Orthopaedic Surgery
Zip code
390-8621
Address
3-1-1 Asahi, Matsumoto, Nagano
TEL
0263-37-2659
seikei@shinshu-u.ac.jp
Public contact
Name of contact person
| 1st name | Shota |
| Middle name | |
| Last name | Ikegami |
Organization
Shinshu University Hospital
Division name
Department of Rehabilitation Medicine
Zip code
390-8621
Address
3-1-1 Asahi, Matsumoto, Nagano
TEL
0263-37-2659
Homepage URL
seikei@shinshu-u.ac.jp
Sponsor or person
Institute
Shinshu University
Institute
Department
Personal name
Funding Source
Organization
Shinshu University
Organization
Division
Category of Funding Organization
Other
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Ethics Committee of Shinshu University School of Medicine
Address
3-1-1 Asahi, Matsumoto, Nagano
Tel
0263-37-3099
mdrinri@shinshu-u.ac.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2026 | Year | 03 | Month | 20 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Open public recruiting
Date of protocol fixation
| 2026 | Year | 02 | Month | 10 | Day |
Date of IRB
| 2026 | Year | 02 | Month | 10 | Day |
Anticipated trial start date
| 2026 | Year | 03 | Month | 18 | Day |
Last follow-up date
| 2031 | Year | 03 | Month | 31 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
We conduct regular checkups.
Management information
Registered date
| 2026 | Year | 03 | Month | 18 | Day |
Last modified on
| 2026 | Year | 03 | Month | 18 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000069772
